STRATEGIC PRE-CLINICAL PRODUCT DEVELOPMENT LIMITEDActive
Key figures
STRATEGIC PRE-CLINICAL PRODUCT DEVELOPMENT LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024/25Balance sheet structure
Filed accounts2020/21–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Profit for the year | — | — | 8,178 | -27,563 | 23,927 |
| Cash at bank and in hand | 2,506 | 421 | 9,020 | 976 | 3,268 |
| Total assets | 5,354 | 1,227 | 14,179 | 2,637 | 35,050 |
| Total liabilities | 1,247 | 439 | 4,962 | — | 29,310 |
| Net assets / total equity | 4,899 | 1,460 | 9,788 | -17,775 | 6,152 |
| Average number of employees | 0 | 0 | 1 | 1 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: STRATEGIC PRE-CLINICAL PRODUCT DEVELOPMENT LIMITED
Company
STRATEGIC PRE-CLINICAL PRODUCT DEVELOPMENT LIMITED is a private limited company registered with Companies House under company number 09234622. It was incorporated on 25 Sep 2014. Its status is active. The registered office is in Durham (DH1). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).
Accounts
The latest accounts in the database are for 2024/25 (period ending 30 Sep 2025); the company files abridged accounts (unaudited). Profit for the year was £23,927. Net assets were £6,152, up 134.6% on the previous year. Cash at bank and in hand was £3,268. Total assets were £35,050 and total liabilities £29,310. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 15 Sep 2027.